# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001140361-23-020956
Filing Date
2023-04-27
Accepted
2023-04-27 16:19:44
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-27

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM ARS | ny20007126x4_ars.pdf | ARS | 920384
| Complete submission text file | 0001140361-23-020956.txt |  | 1268964

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 000-23186 | Film No.: 23857272
SIC: 2836 Biological Products, (No Diagnostic Substances)